ScholarIQanswers from OpenAlex

Current advances in nanozyme-based nanodynamic therapies for cancer

PaperCitations, authors & open-access status

Current advances in nanozyme-based nanodynamic therapies for cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Current advances in nanozyme-based nanodynamic therapies for cancer have?

ScholarIQcitation count

Current advances in nanozyme-based nanodynamic therapies for cancer has 46 citations in the OpenAlex counts ScholarIQ stores.

When was Current advances in nanozyme-based nanodynamic therapies for cancer published?

ScholarIQyear

Current advances in nanozyme-based nanodynamic therapies for cancer has 2024 year in the ScholarIQ index.

What is the open-access status of Current advances in nanozyme-based nanodynamic therapies for cancer?

ScholarIQoa status

Current advances in nanozyme-based nanodynamic therapies for cancer has closed oa status in the ScholarIQ index.

What is the DOI of Current advances in nanozyme-based nanodynamic therapies for cancer?

ScholarIQdoi

The DOI for Current advances in nanozyme-based nanodynamic therapies for cancer is on the source record.

What is the PMID of Current advances in nanozyme-based nanodynamic therapies for cancer?

ScholarIQpmid

The PMID for Current advances in nanozyme-based nanodynamic therapies for cancer is on the source record.

What is the OpenAlex record for Current advances in nanozyme-based nanodynamic therapies for cancer?

ScholarIQopenalex

The OpenAlex for Current advances in nanozyme-based nanodynamic therapies for cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial